Star Trek: Phase II

Ipsen Announces Withdrawal of Palovarotene NDA, Confirming Intention to Re-submit Following Additional Data Analyses

Retrieved on: 
Friday, August 13, 2021
Research, FDA, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Other Science, Science, McNeil Consumer Healthcare, Clinical trial, Muscle, MOVE, Observation, Phase, United, Safety, Review, Research and development, Neglected tropical disease research and development, Company, Food, United Kingdom, FDA, Degenerative disease, New Drug Application, IPN, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Fibrodysplasia ossificans progressiva, Orphanet Journal of Rare Diseases, Tendon, Prevalence, IDMC, Patent, NDA, Risk, PPC, Priority review, ADR, Heterotopic ossification, Heart, HO, Acquisition, Poisson, FOP, Patient, Development, Star Trek: Phase II, Pharmaceutical industry

Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following very recent discussions with the U.S. Food and Drug Administration (FDA), withdrawal of the New Drug Application (NDA) for palovarotene.

Key Points: 
  • Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following very recent discussions with the U.S. Food and Drug Administration (FDA), withdrawal of the New Drug Application (NDA) for palovarotene.
  • As a result, Ipsen has therefore confirmed their withdrawal of the NDA for palovarotene.
  • After recent discussion with FDA, Ipsen plans to resubmit to the FDA upon completion of the additional data analyses.
  • The target regulatory action date assigned by the FDA under a Priority Review status for palovarotene was 30 November 2021.

Plakous Therapeutics Awarded Phase II SBIR Grant from NIH to Continue Development of Therapies for Necrotizing Enterocolitis

Retrieved on: 
Tuesday, August 10, 2021
IND, NEC, Inflammation, Therapy, National, Star Trek: Phase II, Eunice Kennedy Shriver National Institute of Child Health and Human Development, North Carolina State University, SBIR, NICU, Investigational New Drug, Doctor of Philosophy, NIH, View, Multimedia, Small Business Innovation Research, Disease, Principal investigator, Research, Placenta, Pharmaceutical industry

The grant is a follow-on to the Phase I award and will further assist Plakous' development of novel therapies for preventing the devastating and costly disease of premature babies, Necrotizing Enterocolitis (NEC).

Key Points: 
  • The grant is a follow-on to the Phase I award and will further assist Plakous' development of novel therapies for preventing the devastating and costly disease of premature babies, Necrotizing Enterocolitis (NEC).
  • Seth Tomblyn, PhD, Chief Science Officer of Plakous Therapeutics, is the Principal Investigator on the project.
  • "This Phase II grant will build on the success of the Phase I grant from the NIH that allowed Plakous to complete critical development work to demonstrate the consistency and potency of our product in conjunction with North Carolina State University.
  • Plakous Therapeutics is a biotherapeutic company dedicated to researching and developing placenta derived regenerative therapies to improve patient outcomes and reduce health care costs.

Star Trek's Nichelle Nichols to Christen the Real World Federation Headquarters

Retrieved on: 
Thursday, July 1, 2021
Creative works, English-language films, Soft science fiction, Star Trek fandom, Science fiction, Star Trek: Phase II, Trekkie, Star Trek, Gene Roddenberry, James T. Kirk, Roddenberry, Cultural influence of Star Trek

Nichols will meet with fans for autographs, photos and other activities during her trip to Northwest Ohio to officially christen the headquarters of the International Federation of Trekkers on Cleveland Road in Huron.

Key Points: 
  • Nichols will meet with fans for autographs, photos and other activities during her trip to Northwest Ohio to officially christen the headquarters of the International Federation of Trekkers on Cleveland Road in Huron.
  • The Federation is the only Star Trek fan club founded with the approval of series creator Gene Roddenberry.
  • After 36 years of service, the organization moved into its new headquarters facilities in fall of 2020.
  • While at Federation headquarters, Nichols will sign autographs and pose for photos with fans in the replica of Captain James T. Kirk's chair on the Enterprise bridge.

Maya Comerota Joins Tony Robbins and Dean Graziosi for the Own Your Future Challenge

Retrieved on: 
Thursday, May 6, 2021
Creative works, Films, Star Trek: Phase II, Star Trek: The Motion Picture, Cinema of the United States

You already have what you need to enter that industry but now you just need to learn from the best on the planet how to do it.

Key Points: 
  • You already have what you need to enter that industry but now you just need to learn from the best on the planet how to do it.
  • If you don\'t own your economic future, someone else is going to.
  • "\nMaya added, "It is such an honor and a privilege to support Tony and Dean in their mission to transform over a million lives through this challenge, as Tony and Dean have impacted my life in such a profound way.
  • If you want to create your own personal freedom, financially, emotionally, mentally, & physically, this is the way, and Tony and Dean are the best in the industry!

Cast of a Hundred Chronicles the Birth of Star Trek in New Audio Book

Retrieved on: 
Wednesday, March 20, 2019
Creative works, Television series, Television programs, Star Trek: Phase II, Gene Roddenberry, These Are The Voyages, Marc Cushman, Star Trek, Roddenberry, Robert April, Star Trek: The Next Generation

These Are the Voyages Star Trek: The Original Series, Season One (Audio Book)is drawn from the 2014 Saturn Award-winning book of the same title.

Key Points: 
  • These Are the Voyages Star Trek: The Original Series, Season One (Audio Book)is drawn from the 2014 Saturn Award-winning book of the same title.
  • Both the printed book and the new streaming audio book cover the creation of the original Star Trek, the making of its two pilot films, and all 29 episodes of its formative first season (1966-67).
  • "Star Trek creator Gene Roddenberry endorsed this book series over 30 years ago," said author Marc Cushman.
  • "I supervised all the sessions, and the cast included many production people and performers from the original Star Trek.

The Battle for Star Trek Revealed in Newest Volume of Award-Winning Book Series

Retrieved on: 
Monday, March 4, 2019
Creative works, Television series, Star Trek: Phase II, Star Trek, Gene Roddenberry, These Are The Voyages, Book:Star Trek, Star Trek: The Next Generation

This latest volume delivers surprising revelations concerning the decade-long fight to resurrect the series after its 1969 cancellation by NBC.

Key Points: 
  • This latest volume delivers surprising revelations concerning the decade-long fight to resurrect the series after its 1969 cancellation by NBC.
  • And, as he fought to bring Star Trek back, he was usually ignored or disrespected by those in charge."
  • Star Trekfinally returned with a mid-1970s Emmy-winning animated series, then 1979's Star Trek The Motion Picture.
  • These Are the Voyages Gene Roddenberry and Star Trek in the 1970s, Volume 1is now availablefromJacobs/Brown Press.